Business Merck’s stock rallies toward a record after FDA OKs arterial-hypertension drug Posted on March 27, 2024 by miyuru Please enable JS and disable any ad blocker Read More Post navigation How has this $25 billion fund beaten the S&P 500? Patience — and preparing for ‘the next big thing’S&P issues negative outlook on five U.S. regional banks due to office space exposure Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.